国内外对抗凝血药物研究进展迅速,针对不同靶点、不同作用机制的新型药物正在进行临床实验或业已上市.新型抗凝血药物凭着它本身的优势将逐渐代替传统抗凝药物.%At present, the study on anticoagulants develops quickly in recent decades all over the world. The emerging oral anticoagulant agents have target selective and multiple mechanisms, which are undergoing clinical experiment or have gone on the market. The novel anticoagulants will replace gradually traditional anticoagulant agents depending on their inherent advantages.
展开▼
